HomeKIMS › Filing
🔔 Get instant alerts when KIMS files quarterly results on BSE Start free trial →

Monitoring Agency Report

Filed: 03 Aug 2026, 19:09 IST Exchange: NSE Category: Regulatory Compliance — Monitoring Agency Report
Monitoring Agency Report for Q1FY27 on QIP proceeds utilization - Total QIP size: ₹1,500 crore; net proceeds ₹1,476.45 crore - Utilized ₹1,084 crore in Q1FY27; no deviation from offer document - Full ₹910 crore used for repayment of KIMS borrowings - ₹130 crore invested in subsidiaries for repayment; ₹85 crore unutilized - ₹44 crore used for general corporate purposes; ₹307 crore unutilized, temporarily invested in mutual funds - Issue expenses of ₹2.49 crore incurred - No delays or unfavorable events reported - Monitoring proceeds commingled with regular business funds for GCP - Unutilized funds held in mutual funds and bank accounts as per SEBI norms
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 KIMS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add KIMS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Krishna Institute of Medical Sciences Limited

Important. The summary above is generated automatically from Krishna Institute of Medical Sciences Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.